We prospectively studied features of pyogenic bacterial pneumonia in 263 consecutive human immunodeficiency virus -infected inpatients over a 6-month study period. Risk factors for bacterial pneumonia were examined by a case-control study that included 33 cases who presented with at least one episode of bacterial pneumonia and 80 controls without bacterial pneumonia. The estimated cumulative incidence of bacterial pneumonia per year was 12.5 cases per 100 inpatients (95% confidence interval [CI], 8.8 -17.2). The 38 episodes of bacterial pneumonia that occurred in the 33 inpatients were mainly unilateral, but 32 episodes were patchy lobar or diffuse infiltrates. Microbiological etiologies were obtained in 33 of the 38 episodes of bacterial pneumonia. Thirty-seven pathogens were identified, including Streptococcus pneumoniae (16, of which 12 had a decreased susceptibility to penicillin), Haemophilus influenzae (6), and Pseudomonas aeruginosa (6). The risk factors for bacterial pneumonia that were identified after logistic regression included prior sinusitis within 1 month before admission (odds ratio [OR], 3.2; 95% CI, 1.1 -9
Since the beginning of the epidemic of HIV infection, the bacteria have been reported to cause community-acquired pneumonia in HIV-infected patients [13 -15] . incidence of pyogenic bacterial infections among HIV-infected patients has been reported to be higher than that among the To evaluate the incidence and bacterial pathogens of HIVassociated pneumonia and to determine the corresponding risk general population [1, 2] , even individuals with mild immunosuppression [3 -8] . Recurrent bacterial pneumonia is an AIDSfactors, we conducted a case-control study of HIV-infected patients hospitalized in a university hospital in Paris. defining condition according to the criteria of the Centers for Disease Control and Prevention [9] . In addition, bacterial pneumonia is associated with an excess case-fatality rate among
Patients and Methods HIV-infected patients. The main microorganisms involved in these pneumonias are Streptococcus pneumoniae and HaemoPopulation Study philus influenzae [1 -8] .
The incidence of S. pneumoniae strains with decreased susFrom February through July 1994, 263 HIV-infected patients hospitalized in the Department of Infectious Diseases in the ceptibility to penicillin has dramatically increased over the last decade among the general population in Europe. In France, the Pitié-Salpêtrière Hospital, Paris, were eligible for inclusion in the study. All but two patients were residents of the Paris rate of S. pneumoniae -resistant isolates has increased from õ1% to ú20% [10, 11] . In hospitalized HIV-infected patients, metropolitan area. Patients with symptoms of bacterial pneumonia were consecutively enrolled in the study. The choice of cases of infection due to S. pneumoniae with decreased susceptibility to penicillin have been described, thus suggesting nosoantibiotic therapy for bacterial pneumonia was made by the responsible physician and was unaffected by the study. comial transmission [12] . Recently, other emerging pyogenic A case of bacterial pneumonia was defined by either a clinical sign (fever [temperature, §38ЊC], chest pain, cough, purulent sputum, or crackles during auscultation) and radiological signs suggestive of pneumonia associated with positive bacteri-clinical, radiological, and microbiological characteristics of Information on antibiotic treatments received within 1 month before admission was also collected. pneumonia; arterial blood gas levels determined while the patient was breathing room air; antibiotic regimen; and clinical outcome.
Microbiology
Hospital-acquired pneumonia was defined as bacterial pneumonia occurring §2 days after hospitalization without signs Usual standard media were used for bacterial cultures, and Buffer Charcoal Yeast Extract medium (bioMérieux, Marcy of pneumonia at the time of admission.
A microorganism was considered as the causative agent of l'Etoile, France) was used for L. pneumophila culture. Cultures were incubated for at least 5 days at 37ЊC to identify microorbacterial pneumonia if at least one of the following criteria was present: blood culture, culture of pleural fluid, culture of ganisms such as Rhodococcus equi or Bordetella bronchiseptica. All strains were tested for antimicrobial susceptibility. sputum collection, or culture of bronchoscopy-guided protected specimen brush (PSB) (with a threshold of 1,000 cfu/mL [16] )
The tests were performed on Mueller-Hinton agar by the disk diffusion method according to the standards of the French Comyielded a microorganism; or there was positive serology (fourfold rise in titers of serum antibodies at a 14-day interval) for mittee of Antibiogram [17a] . In the case of S. pneumoniae, the medium was supplemented with 5% of defibrinated horse Chlamydia species, Mycoplasma pneumoniae, Coxiella burnetii, or Legionella pneumophila.
blood, and a chocolate agar with polyvitex medium (bioMér-ieux) was used for H. influenzae.
Strains of S. pneumoniae were serotyped with use of immune
Case-Control Study serum provided by the Statens Seruminstitut (Copenhagen). S. pneumoniae with decreased susceptibility to penicillin was On the basis of the data collected prospectively, a casecontrol study was undertaken to examine risk factors for bactedetected with a disk of oxacillin (5 mg), and the MIC was determined by the Etest (AB BIODISK, Solna, Sweden). rial pneumonia. A case was defined as an HIV-infected inpatient with one or more episodes of bacterial pneumonia during Strains of S. pneumoniae were classified as follows: penicillinsusceptible, MIC of £0.1 mg/L; low-level penicillin-resistant, the study period; 33 cases were identified. Controls were HIVinfected patients hospitalized for a reason other than bacterial MIC between ú0.1 and £1 mg/L; and high-level penicillinresistant, MIC of ú1 mg/L. pneumonia. There were two groups of controls: 49 HIV-infected patients hospitalized because of pulmonary disease reSerum samples were tested for antibodies to Chlamydia species, M. pneumoniae, C. burnetii, and L. pneumophila by using lated to HIV infection (such as opportunistic infections or tumoral diseases) who underwent fiberoptic bronchoscopy for microimmunofluorescence assays. microbiological and histological specimen collection, and 31 randomly selected hospitalized HIV-infected patients who did
Statistical Analysis not present with clinical or radiological signs of bacterial pneumonia. These 31 patients were matched to the cases during
The annual cumulative incidence of bacterial pneumonia was estimated as the number of cases of patients presenting with the same week of hospitalization. Because no difference was observed between the two control groups, data for them were at least one episode of bacterial pneumonia during follow-up divided by the number of cases of all HIV-infected patients subsequently pooled for general analysis.
Cases and controls were interviewed by using a standard admitted to the ward during the 6 months of the survey multiplied by two, and the exact binomial 95% confidence questionnaire that included demographic characteristics (age and sex), duration of hospitalization, history of HIV infection interval around the proportion was calculated with use of EpiInfo Version 6.02 (Centers for Disease Control and Prevention, (risk factors for HIV infection, duration of HIV infection, previous pulmonary opportunistic infection, prophylaxis for current Atlanta). Because the distribution of CD4 / lymphocyte counts was opportunistic infection, and CD4
/ lymphocyte count), splenectomy, and polymorphonuclear cell count in blood. Underlying skewed to the left, a natural logarithmic transformation of this value was used for all calculations. The Pearson x 2 test, Fishhealth status was determined by means of the Karnofsky score.
Data on exposure to known risk factors for bacterial pneumoer's exact test, and Student's t test were used for comparisons between cases and controls, and the results were calculated nia in non-HIV-infected patients were also collected, including upper respiratory tract infections [17] (sinusitis, otitis media, with Epi-Info Version 6.02. The relation of each investigated exposure with the occurrence of an episode of bacterial pneuand pharyngitis 1 month before admission), lower respiratory tract infection (6 months before admission), alcoholism, smokmonia was initially assessed by univariate analysis calculating the crude odds ratio with a 95% confidence interval. Adjusted ing, antacid treatments, previous invasive procedures (mechanical ventilation, bronchoscopy, or insertion of a gastric catheter ORs for bacterial pneumonia for which confounding variables were controlled for and 95% confidence intervals were calcuor a central intravascular catheter), deglutition impairment, and exposure to S. pneumoniae and H. influenzae type b vaccines.
lated by using multivariate analysis with logistic regression. Microbiological etiologies were obtained in 33 of the 38 episodes of bacterial pneumonia. Cultures of a PSB (27 epiAs shown in table 4, 12 episodes were due to S. pneumoniae sodes), blood (4), sputum (1), and serum assay (1) yielded the with decreased susceptibility to penicillin, including 10 lowpositive results. In four episodes, two bacterial species were level penicillin-resistant strains and two high-level penicillinidentified by culture of a PSB. As shown in tables 2 and 3, 37 resistant strains. Of these strains, all but one were resistant to pathogens were identified in 33 episodes of bacterial pneumoerythromycin. In both episodes of hospital-acquired pneumonia; 30 were community-acquired pathogens, and seven were nia, the S. pneumoniae strains had decreased susceptibility to hospital-acquired pathogens. Community-acquired pathogens penicillin. The first strain had a low-level penicillin-resistance included S. pneumoniae (14), H. influenzae (6), Pseudomonas and was erythromycin-resistant; the second strain had a highaeruginosa (6), Escherichia coli (2), Moraxella catarrhalis (1), level penicillin-resistance and was erythromycin-resistant. and Chlamydia species (1). Of these pathogens, 18 (58%) were resistant to amoxicillin, and 23 (74%) were resistant to erythroAntibiotic Therapy and Clinical Outcome mycin. Hospital-acquired pathogens included S. pneumoniae (2), E. coli (2) , Klebsiella pneumoniae (1), Staphylococcus
By the third day of empirical antibiotic therapy, the outcome of the four episodes due to S. pneumoniae -susceptible strains aureus (1), and Enterococcus faecium (1 was favorable. Among the 10 episodes due to low-level penicilfor one patient who died of a concomitant fatal opportunistic infection. The two episodes due to high-level penicillinlin-resistant S. pneumoniae, the outcome was favorable in five cases treated with a daily dose of 50 mg of amoxicillin/kg resistant S. pneumoniae had favorable outcomes; patients received either a daily dose of 100 mg of cefotaxime/kg or a (amoxicillin/clavulanate in one) and in two cases treated with a daily dose of 100 mg of cefotaxime/kg. Two failures were regimen of vancomycin and amikacin. The 38 initial episodes were treated with amoxicillin alone observed, one for a patient receiving a daily dose of 50 mg of amoxicillin/kg (along with clavulanate) and one receiving a or in combination (12), amoxicillin/clavulanate (10), oxacillin (1), cefotaxime (11), ceftriaxone (2), ceftazidime (2), erythrodaily dose of 100 mg of cefotaxime/kg. Data were not available mycin (1), amikacin (1), quinolones (5), vancomycin (1), and metronidazole (3). One episode of bacterial pneumonia due to E. coli was con- Holmberg et al. [18] reported that the incidence of bacterial tors [7, 19, 20] have reported that chest roentgenograms most blood should be performed for these patients to provide accurate microbiological results. In this study, blood cultures were positive only for four episodes (10.5%), which is less than the lymphoma (1). None of them had concomitant pyogenic bacterate of 71% previously reported for HIV-infected patients with rial pneumonia. Bacteriologic cultures of bronchoscopy-guided pneumonia by Falco et al. [8] . PSBs were negative.
One or more microbiological agents were identified in 33 of the 38 episodes of bacterial pneumonia. S. pneumoniae was the most common cause of bacterial pneumonia followed by
Case-Control Study
H. influenzae and P. aeruginosa, findings similar to those of previous studies [2 -5, 8, 21, 22] . None of the strains of In the univariate analysis (table 5), cases were more likely than controls to have had sinusitis within 1 month before admis-H. influenzae exhibited amoxicillin resistance associated with b-lactamase production. sion and bronchitis within 6 months before admission (12 of 33 vs. nine of 80 [P õ .002] and 11 of 33 vs. 11 of 80
Pallares et al. [23] reported that HIV infection was a risk factor of bacteremic pneumonia caused by S. pneumoniae with [P õ .01], respectively). Cases were more likely than controls to have had a history of pyogenic bacterial pneumonia in the decreased susceptibility to penicillin. Indeed, most strains of S. pneumoniae with decreased susceptibility to penicillin in previous 6 months, but the difference was not significant (eight of 33 vs. eight of 80 [P Å .07], respectively). Cases were more this study had low-level resistance (MIC between ú0.1 and £1.0 mg/L). This finding explains why most episodes of pneufrequently receiving antiretroviral therapy than were controls (30 of 33 vs. 60 of 80, respectively), but the difference was not monia due to S. pneumoniae with decreased susceptibility to / 9c4a$$ap46 03-09-98 18:40:45 cidas UC: CID penicillin that were treated with a daily dose of amoxicillin of decreased susceptibility to penicillin (serotypes 23, 9, 6, and 14) in France [11] . Most of the S. pneumoniae strains with decreased 50 mg/kg were successfully cured in our study. In contrast, one failure was observed on the third day of treatment when susceptibility to penicillin were resistant to erythromycin. In addition, 75% of all the strains isolated in the study were resistant to a daily dose of cefotaxime of 100 mg/kg was used. Such a discrepancy can be partly explained by variable antibiotic seerythromycin. This high frequency of resistance could be explained by the previous use of macrolides for treatment of respirarum concentrations relative to the MIC of b-lactam antibiotics, but this difference was not assessed in this study.
tory tract infections or M. avium complex infection. The choice of a second-line treatment to b-lactam antibiotics should be conThe serotypes of the S. pneumoniae strains isolated during the study corresponded to those associated with S. pneumoniae with sidered in the scope of this multidrug resistance.
